Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Goodman and Armoyan Buying

<< Previous

Bullboard Posts

Next >>

Comment by longrun86on Sep 27, 2023 1:00pm

184 Views

Post# 35657279

RE:RE:Goodman and Armoyan Buying

I think Armoyan is probably thinking the same things we are.

There is a lot of capital to deploy in the future
There are challenges with operating margins that need to be addressed immediately
The generic sector is struggling
The business development function is underperforming
The business has yet to achieve the required scale it needs
The shares are quite cheap and there should be quite a few opportunities ahead

These are just the reality of our situation (no malice intended).

LR

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism